ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Francesco Onorati
Marisa De Feo
Pasquale Mastroroberto
Francesco Pezzo
Attilio Renzulli
Maurizio Cotrufo
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Onorati, F.
Right arrow Articles by Cotrufo, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Onorati, F.
Right arrow Articles by Cotrufo, M.
Related Collections
Right arrow Coronary disease

Ann Thorac Surg 2005;79:837-845
© 2005 The Society of Thoracic Surgeons


Original article: Cardiovascular

Determinants and Prognosis of Myocardial Damage After Coronary Artery Bypass Grafting

Francesco Onorati, MDa,*, Marisa De Feo, MD, PhDb, Pasquale Mastroroberto, MDa, Lucia Cristodoro, MDa, Francesco Pezzo, MDa, Attilio Renzulli, MD, PhD, FETCSa, Maurizio Cotrufo, MD, FETCSb

a Cardiac Surgery Unit, University Magna Graecia, Catanzaro
b Department of Cardiothoracic Surgery, Second University of Naples, Naples, Italy

Accepted for publication July 23, 2004.

* Address reprint requests to Dr Onorati, Viale dei Pini, 28, 80131 Napoli, Italy (E-mail: frankono{at}libero.it).

BACKGROUND: Myocardial infarction remains a devastating complication after coronary revascularization. Although electrocardiography (ECG) and echocardiography suggest transmural infarction, myocardial damage and the quality of myocardial protection are not recognized unless troponin I (TnI) is assessed. Determinants and prognosis of TnI elevation after coronary artery bypass grafting (CABG) were evaluated.

METHODS: Data of 776 consecutive patients undergoing CABG between January 2002 and January 2004 were prospectively exposed to univariate and multivariate analysis. We evaluated the prognosis of patients with all the ECG, echocardiographic, and biochemical criteria for acute myocardial infarction and that of patients with only TnI elevation. Twelve-month follow-up survival and freedom from cardiac events (FCE) were accomplished.

RESULTS: Troponin I greater than 3.1 µg/L at 12 hours was detected in 6.9% of the population, and correlated with lower in-hospital (p < 0.001) and follow-up survival (p = 0.00001), and lower FCE (p = 0.0009). Twenty-one (38.8%) of these fulfilled ECG-echocardiographic criteria (p = 0.05), demonstrating higher TnI values at 12 (p = 0.001), 24 (p = 0.01), 48 (p = 0.01), and 72 (p = 0.04) hours, prolonged ventilation time (p = 0.001), higher in hospital mortality (p = 0.003), lower follow-up survival (p = 0.023), and lower FCE (p = 0.0084). A EuroSCORE greater than 6, ongoing unstable angina, aortic cross-clamp time greater than 90 minutes, cardiopulmonary bypass time greater than 180 minutes, incomplete revascularization, and intraoperative intraaortic balloon pump were independent predictors of myocardial damage (MD) at multivariate analysis. Combined antegrade and retrograde cardioplegia and postoperative enoximone infusion were associated with a lower TnI elevation.

CONCLUSIONS: Troponin I greater than 3.1 µg/L at 12 hours defines perioperative MD. Associated ECG-echocardiographic criteria indicate acute myocardial infarction and anticipate a worse outcome. Identification of predictors for MD is important to develop preventative strategies, as antegrade plus retrograde cardioplegia and enoximone infusion.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
L. De Santo, G. Romano, A. Della Corte, V. de Simone, F. Grimaldi, M. Cotrufo, and M. de Feo
Preoperative anemia in patients undergoing coronary artery bypass grafting predicts acute kidney injury
J. Thorac. Cardiovasc. Surg., October 1, 2009; 138(4): 965 - 970.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. A. Mohammed, A. K. Agnihotri, R. R.J. van Kimmenade, A. Martinez-Rumayor, S. M. Green, R. Quiroz, and J. L. Januzzi Jr
Prospective, Comprehensive Assessment of Cardiac Troponin T Testing After Coronary Artery Bypass Graft Surgery
Circulation, September 8, 2009; 120(10): 843 - 850.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. Petaja, M. Salmenpera, K. Pulkki, and V. Pettila
Biochemical Injury Markers and Mortality After Coronary Artery Bypass Grafting: A Systematic Review.
Ann. Thorac. Surg., June 1, 2009; 87(6): 1981 - 1992.e3.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
A. S. Rubino, F. Onorati, G. Santarpino, K. Abdalla, S. Caroleo, E. Santangelo, and A. Renzulli
Early intra-aortic balloon pumping following perioperative myocardial injury improves hospital and mid-term prognosis
Interactive CardioVascular and Thoracic Surgery, March 1, 2009; 8(3): 310 - 315.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
E Romagnoli, F Burzotta, C Trani, M Siviglia, G G L Biondi-Zoccai, G Niccoli, A M Leone, I Porto, M A Mazzari, R Mongiardo, et al.
EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention
Heart, January 1, 2009; 95(1): 43 - 48.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
V. A. Mannacio, D. Iorio, V. De Amicis, F. Di Lello, and F. Musumeci
Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial.
J. Thorac. Cardiovasc. Surg., December 1, 2008; 136(6): 1541 - 1548.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
F. Alamanni, L. Dainese, M. Naliato, S. Gregu, M. Agrifoglio, G. L. Polvani, P. Biglioli, A. Parolari, and for the Monzino OPCAB Investigators
On- and off-pump coronary surgery and perioperative myocardial infarction: an issue between incomplete and extensive revascularization.
Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 118 - 126.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
S. J. Durham and J. P. Gold
Late Complications of Cardiac Surgery
Card. Surg. Adult, January 1, 2008; 3(2008): 535 - 548.
[Full Text]


Home page
Clin. Chem.Home page
NACB WRITING GROUP MEMBERS, A. H.B. Wu, A. S. Jaffe, F. S. Apple, R. L. Jesse, G. L. Francis, D. A. Morrow, L. K. Newby, J. Ravkilde, W.H. W. Tang, et al.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Use of Cardiac Troponin and B-Type Natriuretic Peptide or N-Terminal proB-Type Natriuretic Peptide for Etiologies Other than Acute Coronary Syndromes and Heart Failure
Clin. Chem., December 1, 2007; 53(12): 2086 - 2096.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
C. M. Dyke, L. K. Jennings, G. Maier, C. Andreou, R. Daly, and M. R. Tamberella III
Preoperative Platelet Inhibition With Eptifibatide During Coronary Artery Bypass Grafting With Cardiopulmonary Bypass
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2007; 12(1): 54 - 60.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. Onorati, L. Cristodoro, S. Caroleo, A. Esposito, B. Amantea, E. Santangelo, and A. Renzulli
Troponin I and Lactate From Coronary Sinus Predict Cardiac Complications After Myocardial Revascularization
Ann. Thorac. Surg., March 1, 2007; 83(3): 1016 - 1023.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Patti, M. Chello, D. Candura, V. Pasceri, A. D'Ambrosio, E. Covino, and G. Di Sciascio
Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) Study
Circulation, October 3, 2006; 114(14): 1455 - 1461.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. K. Smith, M. Carrier, J. C. Chen, A. Haverich, J. H. Levy, P. Menasche, S. K. Shernan, F. Van de Werf, P. X. Adams, T. G. Todaro, et al.
Effect of pexelizumab in coronary artery bypass graft surgery with extended aortic cross-clamp time.
Ann. Thorac. Surg., September 1, 2006; 82(3): 781 - 788.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. Onorati, L. Cristodoro, M. Bilotta, B. Impiombato, F. Pezzo, P. Mastroroberto, A. di Virgilio, and A. Renzulli
Intraaortic balloon pumping during cardioplegic arrest preserves lung function in patients with chronic obstructive pulmonary disease.
Ann. Thorac. Surg., July 1, 2006; 82(1): 35 - 43.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Thielmann, P. Massoudy, B. R. Jaeger, M. Neuhauser, G. Marggraf, S. Sack, R. Erbel, and H. Jakob
Emergency re-revascularization with percutaneous coronary intervention, reoperation, or conservative treatment in patients with acute perioperative graft failure following coronary artery bypass surgery.
Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 117 - 125.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
S. Al-Ruzzeh, S. George, M. Bustami, J. Wray, C. Ilsley, T. Athanasiou, and M. Amrani
Effect of off-pump coronary artery bypass surgery on clinical, angiographic, neurocognitive, and quality of life outcomes: randomised controlled trial
BMJ, June 10, 2006; 332(7554): 1365.
[Abstract] [Full Text] [PDF]


Home page
MMCTSHome page
M. P. Siegenthaler
Antegrade administration of cardioplegia
MMCTS, June 28, 2005; 2005(0628): 695.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The Society of Thoracic Surgeons.